UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 99

Sortiert nach

Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis

Nature communications, 2017-04, Vol.8 (1), p.15016-15016, Article 15016

2017

Link zum Volltext

Verfügbarkeit prüfen

Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)

Journal of thoracic oncology, 2021-09, Vol.16 (9), p.1501-1511

2021

Link zum Volltext

Verfügbarkeit prüfen

Systemic therapies for hepatocellular carcinoma

Drug Discoveries & Therapeutics, 2015, Vol.9(5), pp.352-362

2015

Link zum Volltext

Verfügbarkeit prüfen

AKR1C3 promotes progression and mediates therapeutic resistance by inducing epithelial-mesenchymal transition and angiogenesis in small cell lung cancer

Translational oncology, 2024-09, Vol.47, p.102027, Article 102027

2024

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive analysis the prognostic and immune characteristics of mitochondrial transport-related gene SFXN1 in lung adenocarcinoma

BMC cancer, 2024-01, Vol.24 (1), p.94-94, Article 94

2024

Link zum Volltext

Verfügbarkeit prüfen

Cell-derived microvesicles mediate the delivery of miR-29a/c to suppress angiogenesis in gastric carcinoma

Cancer letters, 2016-06, Vol.375 (2), p.331-339

2016

Link zum Volltext

Verfügbarkeit prüfen

A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis

European journal of cancer (1990), 2011-03, Vol.47 (5), p.784-791

2011

Link zum Volltext

Verfügbarkeit prüfen

Exosomal miR-27a Derived from Gastric Cancer Cells Regulates the Transformation of Fibroblasts into Cancer-Associated Fibroblasts

Cellular physiology and biochemistry, 2018-01, Vol.49 (3), p.869-883

2018

Link zum Volltext

Verfügbarkeit prüfen

Quantification of preexisting lung ground glass opacities on CT for predicting checkpoint inhibitor pneumonitis in advanced non-small cell lung cancer patients

BMC cancer, 2024-02, Vol.24 (1), p.269-269, Article 269

2024

Link zum Volltext

Verfügbarkeit prüfen

Conteltinib (CT-707) in patients with advanced ALK-positive non-small cell lung cancer: a multicenter, open-label, first-in-human phase 1 study

BMC medicine, 2022-11, Vol.20 (1), p.453-15, Article 453

2022

Link zum Volltext

Verfügbarkeit prüfen

Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma

Scientific reports, 2015-08, Vol.5 (1), p.12921-12921, Article 12921

2015

Link zum Volltext

Verfügbarkeit prüfen

miRNA27a Is a Biomarker for Predicting Chemosensitivity and Prognosis in Metastatic or Recurrent Gastric Cancer

Journal of cellular biochemistry, 2014-03, Vol.115 (3), p.549-556

2014

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of selpercatinib in Chinese patients with advanced RET fusion-positive non-small-cell lung cancer: a phase II clinical trial (LIBRETTO-321)

Therapeutic advances in medical oncology, 2022, Vol.14, p.175883592211050-17588359221105020

2022

Link zum Volltext

Verfügbarkeit prüfen

Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancer

Protein & cell, 2016-02, Vol.7 (2), p.141-151

2016

Link zum Volltext

Verfügbarkeit prüfen

ACT001 inhibits the proliferation of non‐small cell lung cancer cells by upregulating NKTR expression

Thoracic cancer, 2022-06, Vol.13 (12), p.1772-1782

2022

Link zum Volltext

Verfügbarkeit prüfen

Author Correction: Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis

Nature communications, 2023-03, Vol.14 (1), p.1700-1700, Article 1700

2023

Link zum Volltext

Verfügbarkeit prüfen

Anlotinib plus icotinib as a potential treatment option for EGFR-mutated advanced non-squamous non-small cell lung cancer with concurrent mutations: final analysis of the prospective phase 2, multicenter ALTER-L004 study

Molecular cancer, 2023-08, Vol.22 (1), p.124-124, Article 124

2023

Link zum Volltext

Verfügbarkeit prüfen

Tumor necrosis factor superfamily 15 promotes lymphatic metastasis via upregulation of vascular endothelial growth factor‐C in a mouse model of lung cancer

Cancer science, 2018-08, Vol.109 (8), p.2469-2478

2018

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab/PD-1 inhibitor plus chemotherapy as first-line treatment of advanced non-squamous non-small-cell lung cancer

Journal of comparative effectiveness research, 2023-05, Vol.12 (5), p.e230006-e230006

2023

Link zum Volltext

Verfügbarkeit prüfen

Upregulation of GNPNAT1 Predicts Poor Prognosis and Correlates With Immune Infiltration in Lung Adenocarcinoma

Frontiers in molecular biosciences, 2021-03, Vol.8, p.605754-605754

2021

Link zum Volltext

Verfügbarkeit prüfen

Exosome miR‐27a‐3p secreted from adipocytes targets ICOS to promote antitumor immunity in lung adenocarcinoma

Thoracic cancer, 2020-06, Vol.11 (6), p.1453-1464

2020

Link zum Volltext

Verfügbarkeit prüfen

The effects of tislelizumab treatment on the health‐related quality of life of patients with advanced non‐small cell lung cancer

Cancer medicine (Malden, MA), 2023-08, Vol.12 (16), p.17403-17412

2023

Link zum Volltext

Verfügbarkeit prüfen

Patient-reported outcomes following selpercatinib treatment in Chinese patients with advanced RET fusion-positive non-small-cell lung cancer and thyroid cancer, and RET-mutant medullary thyroid cancer in the phase II LIBRETTO-321 trial

Therapeutic advances in medical oncology, 2023-01, Vol.15, p.17588359231189429-17588359231189429

2023

Link zum Volltext

Verfügbarkeit prüfen

The prevalence and real‐world therapeutic analysis of Chinese patients with KRAS‐Mutant Non‐Small Cell lung cancer

Cancer medicine (Malden, MA), 2022-10, Vol.11 (19), p.3581-3592

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(95)

Publikationsform

Artikel
(97)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(14)
Cancer Research
(6)
Journal Of Thoracic Oncology
(4)
Oncotarget
(4)
Therapeutic Advances In Medical Oncology
(4)
Thoracic Cancer
(4)
Bmc Cancer
(3)
Cancer Letters
(3)
Eclinicalmedicine
(3)
Lung Cancer
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis

Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)

Systemic therapies for hepatocellular carcinoma

AKR1C3 promotes progression and mediates therapeutic resistance by inducing epithelial-mesenchymal transition and angiogenesis in small cell lung cancer

Comprehensive analysis the prognostic and immune characteristics of mitochondrial transport-related gene SFXN1 in lung adenocarcinoma

Cell-derived microvesicles mediate the delivery of miR-29a/c to suppress angiogenesis in gastric carcinoma

A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis

Exosomal miR-27a Derived from Gastric Cancer Cells Regulates the Transformation of Fibroblasts into Cancer-Associated Fibroblasts

Quantification of preexisting lung ground glass opacities on CT for predicting checkpoint inhibitor pneumonitis in advanced non-small cell lung cancer patients

Conteltinib (CT-707) in patients with advanced ALK-positive non-small cell lung cancer: a multicenter, open-label, first-in-human phase 1 study

Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma

miRNA27a Is a Biomarker for Predicting Chemosensitivity and Prognosis in Metastatic or Recurrent Gastric Cancer

Efficacy and safety of selpercatinib in Chinese patients with advanced RET fusion-positive non-small-cell lung cancer: a phase II clinical trial (LIBRETTO-321)

Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancer

ACT001 inhibits the proliferation of non‐small cell lung cancer cells by upregulating NKTR expression

Author Correction: Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis

Anlotinib plus icotinib as a potential treatment option for EGFR-mutated advanced non-squamous non-small cell lung cancer with concurrent mutations: final analysis of the prospective phase 2, multicenter ALTER-L004 study

Tumor necrosis factor superfamily 15 promotes lymphatic metastasis via upregulation of vascular endothelial growth factor‐C in a mouse model of lung cancer

Bevacizumab/PD-1 inhibitor plus chemotherapy as first-line treatment of advanced non-squamous non-small-cell lung cancer

Upregulation of GNPNAT1 Predicts Poor Prognosis and Correlates With Immune Infiltration in Lung Adenocarcinoma

Exosome miR‐27a‐3p secreted from adipocytes targets ICOS to promote antitumor immunity in lung adenocarcinoma

Baseline C-reactive protein predicts efficacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: a retrospective, multicenter study

The effects of tislelizumab treatment on the health‐related quality of life of patients with advanced non‐small cell lung cancer

Patient-reported outcomes following selpercatinib treatment in Chinese patients with advanced RET fusion-positive non-small-cell lung cancer and thyroid cancer, and RET-mutant medullary thyroid cancer in the phase II LIBRETTO-321 trial

The prevalence and real‐world therapeutic analysis of Chinese patients with KRAS‐Mutant Non‐Small Cell lung cancer

Suchergebnisse filtern